帕金森病
医学
疾病
神经科学
重症监护医学
病理
心理学
作者
Ravi Rajmohan,Anna Wen,Claire Henchcliffe
标识
DOI:10.1080/14737175.2025.2515068
摘要
Mounting evidence supports the validity of CSF and skin biopsy-based detection of α-synuclein for the distinction of PD from healthy controls, although not yet from the spectrum of α-synucleinopathies nor from non-α-synuclein forms of parkinsonism. Nonetheless, the potential to detect individuals who will develop PD may revolutionize our ability to test potential preventive interventions before motor symptoms develop. Machine-learning approaches offer promising strategies for efficient identification and validation of novel biomarkers.
科研通智能强力驱动
Strongly Powered by AbleSci AI